In a randomized study in critically ill patients with hypophosphatemia, 30 or 45 mmol of intravenous potassium phosphate corrected phosphate by the end of the infusion in 98%, whether given over 2 or 4 hours (moderate) or 3 or 6 hours (severe), with no adverse events.
emerging — human data exists, and it is thin or contested
every claim resolves to its source
All 1 citation resolves to their original source. · 0 posts naming it, 0 members counted once each.
created page created as 'Potassium phosphate (injectable)' with aliases dipotassium hydrogen phosphate (K2HPO4), monopotassium phosphate (KH2PO4), potassium phosphate for injection · 2026-09-27 12:04 · somebody
kind set kind set to mineral: palette r2 · 2026-09-27 12:04 · somebody
fact added summary: In a randomized study in critically ill patients with hypophosphatemia, 30 or 45 mmol of intravenous potassium phosphate · 2026-09-27 12:04 · somebody